A combination of ribavirin and interferon protects monkeys from the deadly Middle East Respiratory Syndrome coronavirus, and potentially could be used to treat humans, according to a study published in Nature Medicine. Three of six rhesus monkeys were given the drug cocktail eight hours after being infected with MERS, and showed only minimal signs of the virus, while the other three became very ill, researchers said.

Related Summaries